Table 4

BTS treatment step for all asthma patients (n=599) and active asthma patients (n=441) immediately prior to the new oral β-blocker prescription

BTS stepAll asthma patients with β-blockersActive asthma patients with β-blockers
Cardioselective (%)Non-selective (%)Cardioselective (%)Non-selective (%)
1150 (57.7)233 (68.7)89 (44.7)135 (55.8)
269 (26.5)61 (18.0)69 (34.7)61 (25.2)
323 (8.8)27 (8.0)23 (11.6)27 (11.2)
417 (6.5)18 (5.3)17 (8.5)18 (7.4)
Other1 (0.4)1 (0.3)1 (0.5)1 (0.4)
Total260 (100.0)339 (100.0)199 (100.0)242 (100.0)
  • Other, patients with either long-acting β2-agonist or theophylline monotherapy.

  • BTS, British Thoracic Society/Scottish Intercollegiate Guideline Network.